CIK 0001367644 · Accelerated filer
Emergent BioSolutions Inc.
Sign in to watch- Ticker
- EBS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 141902018
- Phone
- 240-631-3200
- Business address
- 300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $145,792
- in 2 filings, $146K under 10b5-1 plans
Net −$145,792. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-09 | Williams Paul Anthony SVP, Products Business | Grant or award | +4,616 | 16,994 | ||
| 2023-06-09 | Williams Paul Anthony SVP, Products Business | Grant or award | +9,231 | 26,225 | ||
| 2023-06-09 | Williams Paul Anthony SVP, Products Business | Grant or award · Employee Stock Option (Right to buy) | +9,231 | 22,614 | ||
| 2023-06-09 | Glessner Coleen EVP, Quality & Ethics, and CPL | Grant or award | +15,385 | 134,579 | ||
| 2023-06-09 | Glessner Coleen EVP, Quality & Ethics, and CPL | Grant or award | +30,770 | 165,349 | ||
| 2023-06-09 | Glessner Coleen EVP, Quality & Ethics, and CPL | Grant or award · Employee Stock Option (Right to buy) | +30,770 | 62,113 | ||
| 2023-06-09 | Fox Jennifer Lynne EVP, Ext Aff, GC, Corp Sec | Grant or award | +24,616 | 129,975 | ||
| 2023-06-09 | Fox Jennifer Lynne EVP, Ext Aff, GC, Corp Sec | Grant or award | +49,231 | 179,206 | ||
| 2023-06-09 | Fox Jennifer Lynne EVP, Ext Aff, GC, Corp Sec | Grant or award · Employee Stock Option (Right to buy) | +49,231 | 98,169 | ||
| 2023-06-09 | LINDAHL RICHARD S EVP, Chief Financial Officer | Grant or award | +24,616 | 123,761 | ||
| 2023-06-09 | LINDAHL RICHARD S EVP, Chief Financial Officer | Grant or award | +49,231 | 172,992 | ||
| 2023-06-09 | LINDAHL RICHARD S EVP, Chief Financial Officer | Grant or award · Employee Stock Option (Right to buy) | +49,231 | 180,944 | ||
| 2023-06-09 | Havey Adam EVP, Business Operations | Grant or award | +24,616 | 125,167 | ||
| 2023-06-09 | Havey Adam EVP, Business Operations | Grant or award | +49,231 | 174,398 | ||
| 2023-06-09 | Havey Adam EVP, Business Operations | Grant or award · Employee Stock Option (Right to buy) | +49,231 | 161,906 | ||
| 2023-06-09 | Kramer Robert President and CEO | Grant or award | +70,769 | 364,520 | ||
| 2023-06-09 | Kramer Robert President and CEO | Grant or award | +141,539 | 506,059 | ||
| 2023-06-09 | Kramer Robert President and CEO | Grant or award · Employee Stock Option (Right to buy) | +141,539 | 535,051 | ||
| 2023-06-02 | Zoon Kathryn C Director | Sale 10b5-1 | −1,830 | $8.35 | $15K | 49,971 |
| 2023-05-25 | Zoon Kathryn C Director | Sale 10b5-1 | −1,700 | $8.38 | $14K | 51,801 |
Page 11 of 17 · 330 trades